abstract |
The present invention provides oligonucleotide analogs comprising modified interunit linkages and / or modified 3 'and / or 5'-terminal groups. The compounds described are useful for the treatment of diseases in which inhibition of protein expression or correction of aberrant mRNA split products provides a beneficial therapeutic effect. |